Literature DB >> 18262347

Annexin A2 localizes to the basal epithelial layer and is down-regulated in dysplasia and head and neck squamous cell carcinoma.

Emma Pena-Alonso1, Juan Pablo Rodrigo, Iñigo Casafont Parra, Juana Maria Garcia Pedrero, Maria Victoria Gonzalez Meana, Carlos Suarez Nieto, Manuel F Fresno, Reginald O Morgan, M Pilar Fernandez.   

Abstract

Annexin A2 is a highly expressed gene with important roles in cell membrane physiology and is frequently dysregulated in cancer. The objective of this study was to determine the pattern of expression and prognostic significance of annexin A2 protein in head and neck squamous cell carcinoma. We assessed both quantitative changes and qualitative distribution of annexin A2 mRNA and protein expression in normal and diseased tissues by immunohistochemistry, immunofluorescence and in situ hybridization. Annexin A2 expression was confined to the basal and suprabasal cells of normal epithelium and the protein cellular location was consistently observed at the cell membrane. Expression levels correlated with histopathological grade, showing significant suppression in moderately and poorly differentiated tumours. We conclude that annexin A2 exhibits a characteristic pattern of expression, distinct from other annexins and suggestive of a cell-specific functional role. The marked reduction of annexin A2 in poorly differentiated tumours and dysplastic tissue is expected to result in a loss of function aimed at the coordination of membrane signalling enzyme complexes, actin polymerization and extracellular matrix proteolysis. The phenotypic consequences may become manifest in an alteration of epithelial tissue growth and remodelling with secondary influence on tumour development, progression and metastasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18262347     DOI: 10.1016/j.canlet.2007.12.029

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  22 in total

1.  Serum annexin A2 levels in acute brucellosis and brucellar spondylodiscitis.

Authors:  N Aktug Demir; S Kolgelier; S Sumer; A C Inkaya; S Ozcimen; L S Demir; O Ural; A Arpaci
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-23       Impact factor: 3.267

2.  ERG oncoprotein inhibits ANXA2 expression and function in prostate cancer.

Authors:  Nicholas B Griner; Denise Young; Pankaj Chaudhary; Ahmed A Mohamed; Wei Huang; Yongmei Chen; Taduru Sreenath; Albert Dobi; Gyorgy Petrovics; Jamboor K Vishwanatha; Isabell A Sesterhenn; Shiv Srivastava; Shyh-Han Tan
Journal:  Mol Cancer Res       Date:  2014-10-24       Impact factor: 5.852

3.  The role of annexin A2 in tumorigenesis and cancer progression.

Authors:  Noor A Lokman; Miranda P Ween; Martin K Oehler; Carmela Ricciardelli
Journal:  Cancer Microenviron       Date:  2011-03-05

4.  Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity.

Authors:  Su-Lin Yang; Ying-Ting Chou; Cheng-Nan Wu; Mei-Shang Ho
Journal:  J Virol       Date:  2011-09-07       Impact factor: 5.103

5.  Identification of cellular targets in human intrahepatic cholangiocarcinoma using laser microdissection and accurate mass and time tag proteomics.

Authors:  Alexandre Dos Santos; Magali Court; Valérie Thiers; Sokhavuth Sar; Catherine Guettier; Didier Samuel; Christian Bréchot; Jérôme Garin; France Demaugre; Christophe D Masselon
Journal:  Mol Cell Proteomics       Date:  2010-05-31       Impact factor: 5.911

6.  Clinical significance of annexin II expression in human non-small cell lung cancer.

Authors:  Jin-Wei Jia; Kun-Lin Li; Jin-Xing Wu; Shu-Liang Guo
Journal:  Tumour Biol       Date:  2013-03-14

7.  Immunohistochemical markers of distant metastasis in laryngeal and hypopharyngeal squamous cell carcinomas.

Authors:  Juan P Rodrigo; Patricia Martínez; Eva Allonca; Laura Alonso-Durán; Carlos Suárez; Aurora Astudillo; Juana María García-Pedrero
Journal:  Clin Exp Metastasis       Date:  2013-12-27       Impact factor: 5.150

8.  The association of annexin A2 and cancers.

Authors:  Xiaohui Zhang; Shuqing Liu; Chunmei Guo; Junwei Zong; Ming-Zhong Sun
Journal:  Clin Transl Oncol       Date:  2012-07-24       Impact factor: 3.405

9.  Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.

Authors:  Qi Zhang; Zaiyuan Ye; Qiong Yang; Xujun He; Huiju Wang; Zhongsheng Zhao
Journal:  World J Surg Oncol       Date:  2012-06-08       Impact factor: 2.754

10.  Annexin II represents metastatic potential in clear-cell renal cell carcinoma.

Authors:  Y Ohno; M Izumi; T Kawamura; T Nishimura; K Mukai; M Tachibana
Journal:  Br J Cancer       Date:  2009-06-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.